Par C210 Pill - blue & yellow capsule/oblong
Pill with imprint Par C210 is Blue & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Par Pharmaceutical Companies, Inc.
Fenofibric acid is used in the treatment of Hypertriglyceridemia; High Cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Par C210
Fenofibric Acid Delayed-Release
- Imprint
- Par C210
- Strength
- 135 mg
- Color
- Blue & Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Companies, Inc.
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
stearic acid,
magnesium silicate,
triethyl citrate,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
D&C Yellow No. 10,
ferrosoferric oxide,
propylene glycol,
shellac,
FD&C Yellow No. 6,
gelatin,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 10370-0210 (Discontinued) | Anchen Pharmaceuticals, Inc. |
| 68084-0715 (Discontinued) | Amerisource Health Services |
More about fenofibric acid
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (25)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
